2009
DOI: 10.1016/j.jmb.2009.06.055
|View full text |Cite
|
Sign up to set email alerts
|

Non-receptor Tyrosine Kinases c-Abl and Arg Regulate the Activity of C/EBPβ

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
12
0

Year Published

2011
2011
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 12 publications
(12 citation statements)
references
References 56 publications
0
12
0
Order By: Relevance
“…Additional conditions enhancing C/EBPβ protein half-life have also been described, e.g. transfection of kinases targeting tyrosine 79 (>6 h) [ 41 ] or suppression of C/EBPβ SUMOylation (>12 h) [ 38 , 40 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Additional conditions enhancing C/EBPβ protein half-life have also been described, e.g. transfection of kinases targeting tyrosine 79 (>6 h) [ 41 ] or suppression of C/EBPβ SUMOylation (>12 h) [ 38 , 40 ].…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, phosphorylation of murine C/EBPβ at threonine 188 has been shown to be protective especially against μ-calpain-dependent degradation [ 39 ]. In human cells, phosphorylation at tyrosine 79 enhances C/EBPβ protein stability [ 41 ], whereas phosphorylation at threonine 235 supports proteolysis [ 50 ].…”
Section: Discussionmentioning
confidence: 99%
“…Indeed, according to the annotation of NCBI (http://www.ncbi.nlm.nih.gov/), ABL2 is a member of the Abelson family of nonreceptor tyrosine protein kinase genes and is v-abl Abelson murine leukemia viral oncogene homolog 2. Interestingly, almost all of the currently reported ABL2-associated cancers have been identified successfully through miR2Gene analysis, including melanoma [15] (FDR = 9.13×10 -9 , rank No.1 in all diseases by miR2Gene), lymphoma [16] (FDR = 4.23×10 -3 ) and leukemia [17,18] (FDR = 1.10×10 -3 ). Analysis also showed that ABL2 is strongly associated with digestive system cancer (FDR = 3.54×10 -5 ), which is further supported by two studies that found ABL2 is involved in gastrointestinal stromal tumors (GISTs) [19,20].…”
Section: Resultsmentioning
confidence: 99%
“…Such protection may have clinical relevance when considering tumours with constitutively-activated kinases upstream of EBPβ. Namely, given the role of EBPβ in Ras-induced transformation and myeloid cancers it is tempting to speculate that pharmacologically preventing EBPβ phosphorylation could make it susceptible to Tribblesmediated degradation, and offer benefit in specific cancers (28,29,40). Phosphorylation of EBPβ further adds to the complexity of COP1-based ubiquitination and phosphorylation, given that ETS-family transcription factor degradation is reduced upon phosphorylation by Src-family kinases (41,42).…”
Section: Discussionmentioning
confidence: 99%
“…To explore additional layers of regulation, we analysed data from phosphosite and observed that C/EBPβ is phosphorylated at Ser77 and Tyr79 within its Tribbles degron. Tyr79 phosphorylation of C/EBPβ occurs via c-Abl and Arg non-receptor tyrosine kinases, resulting in stabilisation of C/EBPβ (28), while Ser77 is phosphorylated in a Ras-dependent manner (29). To test the effect of C/EBPβ degron phosphorylation, we developed a competition assay based on fluorescence polarisation (Fig.…”
Section: C/ebpβ Phosphorylation Antagonises Trib1 Bindingmentioning
confidence: 99%